[Federal Register Volume 80, Number 45 (Monday, March 9, 2015)]
[Notices]
[Pages 12495-12496]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-05200]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: March 5, 2015, 10:00 a.m. to 4:00 p.m. EDT.
    Place: Audio Conference Call and Adobe Connect Pro.
    The ACCV will meet on Thursday, March 5, 2015, from 10:00 a.m. to 
4:00 p.m. (EDT). The public can join the meeting by:
    1. (Audio Portion) Calling the conference Phone Number 877-917-4913 
and providing the following information:
    Leader's Name: Dr. A. Melissa Houston.
    Password: ACCV.
    2. (Visual Portion) Connecting to the ACCV Adobe Connect Pro 
Meeting using the following URL: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work 
directly, and enter as a guest). Participants should call and connect 
15 minutes prior to the meeting in order for logistics to be set up. If 
you have never attended an Adobe Connect meeting, please test your 
connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by 
following URL: http://www.adobe.com/go/connectpro_overview. Call (301) 
443-6634 or send an email to [email protected] if you are having trouble 
connecting to the meeting site.
    Agenda: The agenda items for the March 2015 meeting will include, 
but are not limited to: updates from the Division of Injury 
Compensation Programs (DICP), Department of Justice (DOJ), National 
Vaccine Program Office (NVPO), Immunization Safety Office (Centers for 
Disease Control and Prevention), National Institute of Allergy and 
Infectious Diseases (National Institutes of Health) and Center for 
Biologics, Evaluation and Research (Food and Drug Administration). A 
draft agenda and additional meeting materials will be posted on the 
ACCV Web site (http://www.hrsa.gov/vaccinecompensation/accv.htm) prior 
to the meeting. Agenda items are subject to change as priorities 
dictate.
    Public Comment: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Annie Herzog, DICP, Healthcare Systems Bureau 
(HSB), Health Resources and Services Administration (HRSA), Room 11C-
26, 5600 Fishers Lane, Rockville, MD 20857 or email: [email protected]. 
Requests should contain the name, address, telephone number, email 
address, and any business or professional affiliation of the person 
desiring to make an oral presentation. Groups having similar interests 
are requested to combine their comments and present them through a 
single representative. The allocation of time may be adjusted to 
accommodate the level of expressed interest. DICP will notify each 
presenter by email, mail, or telephone of their assigned presentation

[[Page 12496]]

time. Persons who do not file an advance request for a presentation, 
but desire to make an oral statement, may announce it at the time of 
the public comment period. Public participation and ability to comment 
will be limited to space and time as it permits.
    The logistical challenges of scheduling this meeting delayed an 
earlier publication of this notice.

FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding 
the ACCV should contact Annie Herzog, DICP, HSB, HRSA, Room 11C-26, 
5600 Fishers Lane, Rockville, Maryland 20857, telephone (301) 443-6593, 
or email: [email protected].

Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015-05200 Filed 3-6-15; 8:45 am]
 BILLING CODE 4165-15-P